Abstract
Manganese encephalopathy can occur as a result of occupational exposure and as an unusual complication of parenteral nutrition seen usually in critically ill patients. Diagnosis requires a high index of suspicion as the classic symptoms (parkinsonism) are difficult to elicit in critically ill patients. Risk factors for manganese encephalopathy have been identified and clinicians should be mindful of them. There is a poor correlation between manganese levels and clinical findings and between response to therapy and residual imaging changes. Reliable biomarkers to determine manganese status and to detect Mn toxicity are not widely available. Treatment strategies include stopping the offending agent, using dopamine agonists, and possibly using chelating agents.
Abbreviations
- BBB:
-
Blood–brain barrier
- CSF:
-
Cerebrospinal fluid
- EDTA:
-
Ethylenediaminetetraacetic acid
- EN:
-
Enteral nutrition
- Mn:
-
Manganese
- MRI:
-
Magnetic resonance imaging
- PN:
-
Parenteral nutrition
References
Chalela JA, Bonillha L, Neyens R, Hays A. Manganese encephalopathy: an under-recognized condition in the intensive care unit. Neurocrit Care. 2011;14(3):456–8.
Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed. 2004;17(8):544–53.
de Bie RM, Gladstone RM, Strafella AP, Ko JH, Lang AE. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol. 2007;64(6):886–9.
Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, Taylor WJ, Milla PJ. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet. 1996;347(9010):1218–21.
Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology. 1999;20(2–3):315–23.
Lee JW. Manganese intoxication. Arch Neurol. 2000;57(4):597–9.
Martindale RG, McClave SA, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med. 2009;37(5):1757–61.
Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med. 1993;50(6):510–13.
Reimund JM, Dietemann JL, Warter JM, Baumann R, Duclos B. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr. 2000;19(5):343–8.
Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S. Manganic encephalopathy due to “ephedrone” abuse. Mov Disord. 2007;22(9):1337–43.
Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001;101(3):294–301.
Vanek VW, Borum P, Buchman A, Fessler TA, Howard L, Jeejeebhoy K, Kochevar M, Shenkin A, Valentine CJ. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012;27(4):440–91.
Zheng W, Fu SX, Dydak U, Cowan DM. Biomarkers of manganese intoxication. Neurotoxicology. 2011;32(1):1–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Andrews, C.M., Martin, C.M., Chalela, J.A. (2014). Manganese Encephalopathy as a Complication of Parenteral Nutrition in the Intensive Care Unit. In: Rajendram, R., Preedy, V., Patel, V. (eds) Diet and Nutrition in Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8503-2_83-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8503-2_83-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-8503-2
eBook Packages: Springer Reference MedicineReference Module Medicine